The conference will return to Vienna AirportCity on 23 to 24 October 2024
Category: News
The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
GlobalData emphasises importance of Improved clinical trials
Innovative immunotherapy drug HTL0039732 shows potential in trials
New study highlights potential benefits of menopausal hormone therapy
Promising results for novel orexin agonist in sleep-deprived volunteers
Patients with relapsed multiple myeloma gain access to life-extending therapy
New evidence highlights AI’s potential in early lung cancer detection
Molecular imaging agent 99mTc-maraciclatide to aid in disease prognostication